EMORY STROKE CENTER PHYSICIANS PRESENT RESEARCH AT INTERNATIONAL CONFERENCE

January 24, 1996

Media Contact: Sarah Goodwin at 404/727-5686, e-mail: sgoodwi@emory.edu

WHAT: International Joint Conference on Stroke and Cerebral Circulation

WHERE: River Center Marriott, San Antonio

WHEN: Jan. 25-27, 1996

WHO: Emory researchers are presenting their latest findings in the treatment of stroke:

Marc Chimowitz, M.D., assistant professor, Department of Neurology, Emory University School of Medicine, director, Emory Stroke Center

Factor V Mutation and Cryptogenic Stroke in the Young A recently discovered mutation that predisposes individuals to clot formation in legs also may be associated with stroke in young patients.

Warfarin vs. Antiplatelet Therapy for Symptomatic Intracranial Disease (WASID) Study Description of a planned multicenter study coordinated by Dr. Chimowitz that will compare two antithrombotic therapies (blood thinners) for the prevention of stroke in patients with narrowing of a major artery in the brain.
Michael Frankel, M.D., assistant professor, Department of Neurology, Emory University School of Medicine

Is Cocaine Use a Risk Factor for Stroke?
In a young urban population, crack cocaine did not appear to be a significant risk factor for stroke, while hypertension and heart disease were significant risk factors.

Emergency Management of Stroke Bridging Trial Contained intravenous and intra-arterial thrombolysis is relatively safe and effectively opens blocked cerebral arteries after stroke.

National Institutes of Health tPA stroke trial Patients with acute stroke benefit from intravenous tPA (clotbuster) which is the first proven therapy for acute stroke.

For more general information on The Robert W. Woodruff Health Sciences Center, call Health Sciences News and Information at 404-727-5686, or send e-mail to hsnews@emory.edu.